Literature DB >> 16909412

Distinct telomere length regulation in premalignant cervical and endometrial lesions: implications for the roles of telomeres in uterine carcinogenesis.

Y Maida1, S Kyo, N R Forsyth, M Takakura, J Sakaguchi, Y Mizumoto, M Hashimoto, M Nakamura, S Nakao, M Inoue.   

Abstract

Mouse models show that progressive shortening of telomeres with ageing causes chromosomal instability, which can lead to the initiation of cancer. However, it is unclear what roles telomere shortening plays in human carcinogenesis. The present study has investigated the involvement of telomere dynamics in uterine carcinogenesis. Using telomere-FISH (telo-FISH) assays, telomere lengths in premalignant and malignant cervical and endometrial lesions were measured and compared with chromosomal arm loss or gain. Telo-FISH signals were visualized with Cy3-labelled telomere-specific probes and presented as telomere intensity (TI). Early-stage cervical intraepithelial neoplasias (CINs), especially CIN2, had significantly shorter telomeres than corresponding normal squamous epithelia (p = 0.019), together with increased rates of chromosomal arm loss/gain (p < 0.001). Cervical cancers had relatively short telomeres, but they also showed greater heterogeneity than other sampled tissues, including those with long telomeres. In contrast, there was no significant difference between the telomere length of normal endometrium and of endometrial hyperplasia and endometrial cancer. There was no significant difference in the rate of chromosomal arm loss/gain between normal endometrium and endometrial hyperplasia. These findings suggest that progressive shortening of telomeres occurs in CIN, in association with chromosomal instability, which may play critical roles in cervical carcinogenesis. In contrast, endometrial hyperplasias have relatively stable telomeres without widespread chromosome alteration, implying that endometrial carcinogenesis involves mechanisms distinct from those of cervical carcinogenesis, possibly including microsatellite instability.

Entities:  

Mesh:

Year:  2006        PMID: 16909412     DOI: 10.1002/path.2038

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  7 in total

1.  Telomere length and genetic analyses in population-based studies of endometrial cancer risk.

Authors:  Jennifer Prescott; Monica McGrath; I-Min Lee; Julie E Buring; Immaculata De Vivo
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

Review 2.  Review of Mendelian Randomization Studies on Endometrial Cancer.

Authors:  Jian-Zeng Guo; Qi-Jun Wu; Fang-Hua Liu; Chang Gao; Ting-Ting Gong; Gang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-09       Impact factor: 6.055

3.  Three-dimensional nuclear telomere architecture changes during endometrial carcinoma development.

Authors:  Adrian Danescu; Sandra Herrero Gonzalez; Antonio Di Cristofano; Sabine Mai; Sabine Hombach-Klonisch
Journal:  Genes Chromosomes Cancer       Date:  2013-04-30       Impact factor: 5.006

4.  Comparison of telomere length and association with progenitor cell markers in lacrimal gland between Sjögren syndrome and non-Sjögren syndrome dry eye patients.

Authors:  Motoko Kawashima; Tetsuya Kawakita; Yoshiko Maida; Mizuka Kamoi; Yoko Ogawa; Shigeto Shimmura; Kenkichi Masutomi; Kazuo Tsubota
Journal:  Mol Vis       Date:  2011-05-27       Impact factor: 2.367

5.  Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high-risk HPV-positive women.

Authors:  Xiaojun Chen; Sun Wei; Hongxia Ma; Guangfu Jin; Zhibin Hu; Han Suping; Dake Li; Dong Hang; Xiaohua Wu; Ni Li
Journal:  Cancer Med       Date:  2019-06-26       Impact factor: 4.452

6.  Relative Telomere Length in Peripheral Blood Cells and Hypertension Risk among Mine Workers: A Case-Control Study in Chinese Coal Miners.

Authors:  Sheng-Nan Yu; Shi-Qi Chen; Guo-Quan Fan; Wei-Zhe Pan; Jin Jia; Qian Wang; Li Ma; Ben Li; Mei Qiang; Yu-Lan Qiu; Tong Wang
Journal:  Biomed Res Int       Date:  2020-12-03       Impact factor: 3.411

Review 7.  Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis.

Authors:  Anna Pańczyszyn; Ewa Boniewska-Bernacka; Grzegorz Głąb
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.